- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Concord Drugs Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
| Financial Year | |||||
|---|---|---|---|---|---|
12.37 | 11.69 | 15.64 | 12.78 | 7.52 | |
| Other Income Qtr Cr | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Operating Revenues Qtr | 12.36 | 11.69 | 15.64 | 12.78 | 7.52 |
*All values are in Cr. | |||||
11.49 | 10.86 | 15.29 | 12.15 | 5.91 | |
0.87 | 0.83 | 0.35 | 0.63 | 1.60 | |
0.88 | 0.83 | 0.35 | 0.63 | 1.61 | |
0.34 | 0.34 | 0.39 | 0.39 | 0.39 | |
0.04 | 0.03 | -0.34 | -0.24 | 0.56 | |
0.04 | 0.03 | -0.34 | -0.24 | 0.60 | |
Open Demat Account
Open Demat Account